Background. Human enterovirus (HEV)-71 causes large outbreaks of hand-foot-and-mouth disease with central nervous system (CNS) complications, but the role of HEV-71 genogroups or dual infection with other viruses in causing severe disease is unclear.
Since 1997, countries of the Asia-Pacific rim have been affected by large outbreaks of human enterovirus (HEV)-71-associated hand-foot-and-mouth disease (HFMD), which have resulted in hundreds of thousands of cases and many deaths [1] [2] [3] [4] [5] [6] [7] . HFMD is a common exanthema of young children, characterized by fever, rash on the palms and bottoms of the feet, and ulcers in the oral cavity. Most patients have mild cases of disease, but some patients develop severe neurological complications (i.e., aseptic meningitis, acute flaccid paralysis, and encephalitis) or systemic disease (i.e., shock and cardiac dysfunction). HFMD is caused by enteroviruses (genus Enterovirus, family Picornoviridae), particularly Coxsackie A virus (CAV)-10, CAV-16, and HEV-71, which are mostly transmitted by the fecal-oral route. Phylogenetic studies have divided HEV-71 strains into genogroups A, B, and C, which have been further subdivided [4, [8] [9] [10] . The incidence of CNS disease and other severe complications appears to have varied among outbreaks of HEV-71 infection. The reason for this is unclear, but differences between genogroups [10] [11] [12] and coinfection with other viruses, such as a newly characterized adenovirus [1, 13] , have been postulated. However, comparisons between outbreaks have been hampered by the retrospective nature of many studies and differences in inclusion criteria, definitions of severe disease, and viral diagnostic capabilities. We conducted a prospective, clinical, diagnostic, and molecular virological study of HEV-71-associated HFMD in 1 context for 3.5 years. We focused on risk factors for neurological disease and the putative role of different HEV-71 genogroups and dual infections in pathogenesis.
MATERIALS AND METHODS

Setting.
The study was conducted at the pediatric wards and intensive care unit at Sibu Hospital (Sarawak, Malaysia); it commenced in January 2000 and continued for 3.5 years. This 550-bed hospital serves Sibu (population, 200,000) and receives referrals from district hospitals in the Rejang basin (total population, ∼650,000). The study was approved by the Director of Health for Sarawak (Malaysia) and the Ethics Committee of the Liverpool School of Tropical Medicine (Liverpool, UK). Informed consent was obtained from each child's accompanying parent or guardian.
Case definitions. Because enteroviruses can cause HFMD, CNS infection, or both, children (age 1 month to !12 years) were screened for both of these conditions. Children with HFMD were classified according to an algorithm as having mild HFMD, severe non-CNS-HFMD, or HFMD with CNS complications (figure 1). Children with suspected CNS infection, but no HFMD, were classified as having aseptic meningitis (ASM) or viral encephalitis on the basis of clinical and CSF findings; however, there were no children with enterovirus infection in this last group; thus, they are not discussed further.
Clinical methods. A detailed history was recorded, and a clinical examination was performed by a pediatrician of the study team who looked especially for mucocutaneous lesions and cardiovascular and neurological signs; all details were recorded on standardized forms. For viral culture, specimens were swabbed from the throat and rectum of every patient, as well as from at least 1 of the vesicles on the skin and oral ulcers (if present). Blood samples were obtained for viral studies. In patients with severe disease, complete blood cell count, urea level, electrolyte level, and glucose level were determined, and electrocardiography and echocardiography were performed. CSF specimens were examined for cell count and differential, protein level, and glucose level, and Gram stain, bacterial culture, and viral studies were performed; lumbar puncture was repeated if there was a strong clinical suspicion of viral CNS infection and if the initial examination was not confirmatory. Lumbar puncture was delayed in patients who were severely unhealthy. Patients were examined daily, or more frequently (as indicated), by a member of the study team. Children with HFMD and CNS complications were treated with intravenous immunoglobulin (IVIG; Intragam P-CSL, which is derived from local Malaysian blood donors), on a presumptive basis [1, 14] , at the discretion of the treating physician.
Virological methods. Viral isolation was attempted on all swab specimens, CSF specimens, and any serum samples remaining after other investigations had been completed through the inoculation of rhabdomyosarcoma (Rd) and 293 cells [13] . Isolated enteroviruses were typed by nucleotide sequencing of VP1 and VP4 genes [8, 15] and genogrouped by phylogenetic analysis [8] [9] [10] . Adenoviruses were cultured and typed in accordance with the methods described previously [13] . Paired serum samples (obtained on the day of admission, on day 7, or on the day of discharge) and CSF specimens were also tested for IgM against dengue and Japanese encephalitis virus (JEV) in parallel, using an IgM capture ELISA [16] . Seroconversion from a negative result to a positive result for a second sample or an increasing IgM optic density was considered evidence of acute infection; antibody in the CSF was diagnostic of flavivirus CNS infection [17, 18] . A decreasing IgM optic density was considered evidence of a recent infection, and low IgM optic density in the serum of children recently vaccinated against JEV was ascribed to vaccination.
Statistical analysis. Normally distributed data were compared using Student's t test; data that were not normally distributed were compared by the Mann-Whitney U test (Staview 4.02; Abacus Concepts). Differences between proportions were tested using the x 2 test with Yates's correction or Fisher's exact test (EpiInfo, version 6; Centers for Disease Control and Prevention). Variables that might relate to disease pathogenesis that were associated with CNS disease in univariate analyses were also examined in a stepwise logistic regression (SPSS software, version 9; SPSS).
RESULTS
Epidemiology
During the study, 773 children (485 boys [63%]) were recruited. Five hundred forty children (70%) had mild HFMD; 83 (11%) had severe HFMD with no CNS complications; 102 (13%) had HFMD with CNS disease, 3 of whom died; and 48 (6%) had ASM, 1 of whom died. Most of the children were recruited during 2 large outbreaks of HEV-71-associated HFMD during 2000, 2001, and 2003 (figure 2). Genogroup analysis showed that in the outbreak that occurred during 2000-2001, most HEV-71 isolates belonged to genogroup B4 [9, 10] , and some belonged to C1. In 2003, in addition to genogroup C1 strains, a previously undescribed genogroup, which has been named B5, emerged during the outbreak.
Most of the patients entered the study once, but 4 boys were admitted to the study twice. For the purposes of analysis, each hospitalization was considered to be a separate entity. Thirteen other children had also been hospitalized in the past with Figure 1 . Algorithm showing the classification of patients in the study. Because human enterovirus (HEV)-71 can cause hand-foot-and-mouth disease (HFMD), CNS infection, or both, children with HFMD or suspected CNS infection were studied. Cases of HFMD were classified as mild HFMD, severe non-CNS HFMD, and HFMD complicated by CNS disease; children with viral CNS infection were classified as having aseptic meningitis (ASM) or viral encephalitis, but there were no children in the latter group infected with enteroviruses during this study. The final number of patients infected with HEV-71 in each diagnostic group is shown in the figure. T, temperature. *Herpangina was defined as multiple oral ulcers predominantly affecting the posterior parts of the oral cavity.
HFMD (outside the study). For 211 children (27%), there was a history of contact with another person infected with HFMD. One hundred three children (13%) had at least 1 other child in the family (sibling or cousin; maximum, 4) admitted into the study and were considered to be part of a family cluster. Seventy-seven of the children of these 44 family clusters had mild disease, 9 had severe non-CNS HFMD, and 17 had HFMD with CNS complications. When the index case of a family cluster could be identified clearly, they were no more or less likely to have CNS disease than subsequent cases. Forty-one of the children in family clusters had HEV-71 isolated (with only 1 genogroup isolated from each family); 3 of these children also had CAV-16 isolated; thus, in 2 families, both CAV-16 and HEV-71 were isolated. Twelve other children had CAV-16, and 3 had other viruses.
Virology
Dual infections. We attempted virus isolation on 3006 samples (622 throat swab specimens, 631 rectal swab specimens, 768 mouth ulcer swab specimens, 706 vesicle swab specimens, 91 serum samples, and 188 CSF samples) from 672 (87%) of the 773 patients seen during the study period. There were no important demographic differences between those who were investigated and those who were not investigated. Two hundred seventy-seven patients (41%) had HEV-71 isolated. Twenty- eight of these patients with HEV-71 had a second virus isolated, including 14 patients coinfected with CAV-16 and 9 coinfected with other enteroviruses (CAV-4, CAV-5, CA-16, CAV-10, Echo 25, CBV-1, and CAV-24); 1 of each was coinfected with an oral polio vaccine virus, an untyped enterovirus, adenovirus (Ad)-1 (isolated from the rectum), Ad7 (rectum), or an unidentified virus (isolated from the CSF). CAV-16 was isolated from an additional 85 patients, 4 of whom had coinfection; 2 had CBV-1 isolated from the throat, and 2 had adenoviruses isolated from the rectum (Ad2 in one and Ad4 in the other). Fiftyeight patients were infected with other enteroviruses, adenoviruses, or unidentified viruses (12 of whom had multiple viruses isolated). Most of the presenting clinical features of the HEV-71-infected and virus-isolation-negative patients were similar, with the exception of 26 (10%) of the 252 patients who had no virus isolated and had seizures, compared with only 6 (2%) of the 263 patients infected with HEV-71 (OR, 0.20; 95% CI, 0.07-0.53;
). P ! .001 Seven hundred sixteen patients had serum samples, and, when available, CSF specimens (233 patients) tested for antibodies to JEV and dengue. Three patients had serological evidence of acute JEV infection, including a girl with mild HFMD and HEV-71 isolated from vesicles and the throat and a boy with mild HFMD and fever who had HEV-71 isolated from vesicles and CAV-16 isolated from the throat that had acute peripheral JEV infection (seroconversion in the serum). In addition, an 18-month-old boy with HFMD and CNS disease (manifested by a generalized seizure and a CSF pleocyte level of 10 cells/mL) had CAV-16 isolated from a vesicle, which seroconverted to JEV in both the serum and CSF; he made a full recovery. Three patients had acute dengue. All had HFMD and CNS disease (defined as lethargy, irritability, and CSF pleocytosis) and HEV-71 isolated (1 from the CSF, 1 from the throat and vesicles, and 1 from vesicles and the rectum). Dengue was diagnosed by IgM seroconversion, but there was no dengue antibody in the CSF. Two patients with HFMD had serological evidence of a recent JEV infection or recent vaccination, and 6 patients had serological evidence of recent dengue. Only 2 of the children with CAV-16 and HFMD had CNS disease; 1 of these was the child coinfected with JEV described above and For both trees, sequence from the prototype Coxsackie A virus (CVA)-16-G10 was used as an outgroup. The year of isolates is given as a suffix, and Genbank accession numbers are in parentheses. Horizontal branch lengths are proportional to the number of nucleotide changes between viruses, and the scale and the bootstrap values in 1000 pseudoreplicates for major lineages within the dendrogram are shown as percentages. PCR products were sequenced using Big Dye, version 3.0, and run on an ABI377 automated sequencer (Applied Biosciences), and nucleotide sequences were aligned (DNASTAR). (Figure 3 continued) for the other child, CAV-16 was isolated from rectal and vesicle swab specimens, and CBV-1 was isolated from the throat.
HEV-71 genogroups. Phylogenetic analysis of all 277 HEV-71 isolates showed that 168 (61%) of the isolates belonged to genogroup B4 (165 of these were isolated in 2000, 1 was isolated in 2002, and 2 were isolated in 2003), and 68 (25%) of the isolates belonged to C1 (4 of these were isolated in 2000, and 64 were isolated in the 2003 outbreak); in addition, 41 HEV-71 strains (15%) isolated in 2003 were from a new genogroup (B5) that emerged during the course of the study [9, 19, 20] . Neighbor-joining trees of the VP1 (figure 3A) and VP4 ( figure  3B ) genes revealed that representative HEV-71 strains from all 3 genogroups (B4, B5, and C1), described at Sibu, clustered tightly with bootstrap support values 190% and 170%, respectively.
Clinical Features of HEV-71 Infection
Nearly two-thirds of the patients with HEV-71 infection had mild HFMD; 12% had severe non-CNS disease, 19% had HFMD with CNS disease, and only 1% had ASM (table 1) . For the purposes of analysis, patients with CNS infection, defined by a CSF pleocytosis (with or without HFMD), were compared with patients with no CNS disease (including mild and severe non-CNS HFMD). Patients with CNS disease were younger and were more likely to give a history of fever, vomiting, mouth ulcers, breathlessness, cold limbs, poor urine output, and neurological features, including altered sensorium and seizures (table 1). During examination, patients with CNS disease were more likely to look toxic, be dehydrated and febrile, have altered consciousness, and experience neck stiffness, but they were less likely to have mouth ulcers (table 2) . Excluding the 4 patients with ASM and no rash did not significantly alter these findings. The CSF was examined in 90 children (34%) infected with HEV-71, of whom 56 (62%) had a CSF WBC count 15 cells/ mL. For these patients, the median WBC count was 75 cells/ mL (range, 6-1090 cells/mL). Typically, this was a lymphocytic CSF with a normal glucose ratio, but 12 (21%) had neutrophil predominance, and 10 (18%) had a CSF to plasma glucose ratio !50%.
Three children had HFMD complicated by acute flaccid paralysis; 1 had HEV-71-B4 genogroup isolated from his throat, and the 2 others had negative culture results. Sixty-two children with severe HFMD had cardiac enzyme levels measured (27 children with HEV-71). Seventy-eight of the 233 patients with more severe HFMD were treated with IVIG on a presumptive basis, including 42 patients who were infected with HEV-71. Five patients with HEV-71 required ionotropic support, and 3 required ventilation. Four children died, including 2 who had HEV-71 isolated (1 genogroup B4 and 1 genogroup C1).
Pathogenesis of Neurological HEV-71 Disease
Children from whom HEV-71 and another virus were isolated were no more likely than those with HEV-71 alone to have neurological involvement ( ). Genogroup, age, and being part of a family P ! .0001 cluster were initially entered into a multiple logistic regression model; increasing age and genogroup B4 versus C1 were associated with a reduced risk of CNS infection (table 3) , whereas being in a family cluster did not affect risk.
DISCUSSION
Since 1997, HEV-71 infection has become a major public health problem in developed and developing countries in the AsiaPacific region, and it has the potential to spread further. Mo- 34 (12) 221 (80) 52 (19) 4 (1) 56 ( (68) 34 (12) 221 (80) 52 (19) 4 (1) 56 ( NOTE. Genogroup, age, and being part of a family cluster were initially entered into a multiple logistic regression model. Terms were entered into the model and remained only if they were statistically associated with CNS disease ( ). Both forward selection and backward elimination methods were P ! .05 used. Increasing age and genogroup B4 versus C1 were associated with a reduced risk of CNS infection, whereas being in a family cluster did not affect risk. Forward selection and backward elimination procedures generated the same model, indicating its robustness. The Hosmer-Lemeshow statistic indicated a nonsignificant lack of fit (x 2 , 8.338; ). P p .401 lecular epidemiological studies have documented remarkable changes in the circulating HEV-71 genogroups in the AsiaPacific region during this time [9, 10, [21] [22] [23] . However, whether such genetic differences explain the differing clinical presentations is not clear [4, 24] . Other postulated factors include differences in pre-existing immunity of the pediatric population [25] , differences in host genetic susceptibility [12, 26, 27] , and coinfection with other viruses [1] . Our detailed investigation of 773 patients, which included 277 patients with HEV-71 infection, has produced intriguing clinical epidemiological evidence and suggests that the behavior of genogroups of HEV-71 may differ. Children infected with genogroup B4 were less likely to present with CNS infection than those infected with C1 or B5 and were also less likely to be part of a family cluster. In contrast, children infected with B5 were more likely to be part of a family cluster, and there was a trend towards a greater incidence of CNS disease in these patients.
However, our findings must be interpreted with caution. Although we attempted to minimize confounding variables, there were factors beyond our control. In particular, the likelihood of children presenting to the hospital with HFMD may have varied during the study, although altered referral rates would be unlikely to explain the different risk of family clustering for the different genogroups. There may also have been other inherent features that differed between the cohort studied in 2000 and 2003, although the basic demographic features were similar (data not shown).
Our study has also confirmed findings from earlier reports that young age, fever, vomiting, and hyperglycemia are associated with severe HEV-71 infection [28, 29] ; in addition, we found tachycardia, breathlessness, and the absence of mouth ulcers were associated with CNS disease. Overall, the incidence of severe disease was milder in our study than in previous studies, because only 4 fatalities occurred in our study, all of which were a result of pulmonary edema. In addition, our series was unusual in having only 4 patients with pure aseptic meningitis.
Our study has also made an important contribution to the debate about the role of dual infections in viral CNS disease. As others have shown previously [30] , we found several enteroviruses were cocirculating during the HFMD outbreaks. We also documented instances of coinfection of HEV-71 with other enteroviruses in individual patients. We found no evidence of an increased likelihood of CNS disease in such patients, although we did find an intriguing association of coinfection with dengue viruses and neurological presentation. Previously, we postulated that a new adenovirus type 21 might make an important contribution to fatal disease during an HEV-71-associated HFMD outbreak [1, 13] ; in this new study, we isolated adenoviruses from only 4 patients, and none was adenovirus type 21. Our rigorous investigations for multiple viral agents showed the importance of pursuing all possible avenues before attributing causation to the first pathogen encountered. For example in 2 children, CNS disease would have been attributed to CAV-16, which is an unusual cause of CNS disease, had our thorough diagnostic examination not revealed alternative, more likely viral causes (JEV in 1 child and CBV-1 in the other). Whether unsuspected dual infections lie behind other unusual manifestations of common, relatively benign enteroviruses, such as acute flaccid paralysis recently attributed to CAV-24 [31] , is not known .
In summary, our detailed study provides clinical epidemiological evidence for different biological behavior of HEV-71 genogroups, with regard to transmissibility within families and risk of CNS disease. It also highlights the importance of detailed investigations for multiple pathogens during HFMD outbreaks. Only with such thorough investigations will the pathophysiology of HEV-71 be fully determined.
